Leo Laboratories Limited

Longwick Road, Princes Risborough, Bucks., HP27 9RR
Telephone: +44 (0)1844 347 333
Fax: +44 (0)1844 276 385
Medical Information e-mail: medical-info.uk@leo-pharma.com

Summary of Product Characteristics last updated on the eMC: 15/05/2006
SPC Bumetanide Injection 0.5mg/ml, solution for injection (Leo Laboratories Ltd)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 15/05/2006 and displayed until Current
Reasons for adding or updating:
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change from BAN to rINN
Date of revision of text on the SPC:   30/11/05
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 5.2 Pharmacokinetic Properties: Frusemide amended to furosemide
Updated on 19/10/2001 and displayed until 15/05/2006
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change from datasheet to SPC

Active Ingredients/Generics

 
   bumetanide